REFERENCES
Baron S., Tyring S. K., Fleischmann, H. G., Coppenhaver W. R., Niesel D. H., Limpel D. W., Stanton G. J., and Hughes T. K. JAMA 266:1375–1383 (1991).
Alam J. Curr Op Biotech 6:688–691 (1995).
Jacobs L, et.al. Ann Neur 39:285–294 (1996).
Alam J., Gorman B., Stannard M., Dawson A., Loynds P., Mant T., and Fox, I. J Interferon Res 11(suppl 1):S246 (1991).
AVONEX™ U.S. Package Insert.
Palimisano L., Salmon P., Cotonnec J. Y., Samra H., and Klasen E. J Interferon & Cytokine Res 10(Suppl 1):S125 (1990).
Salmon P., Le Cotonnec J-Y., Galazka A., Abdul-Ahad A., Darragh A., J Interferon & Cytokine Res 16:759–764 (1996).
Fuchs D., Weiss G., Reibnegger G., Wachter H., Crit Rev Clin Lab Sci 29:307–341 (1992).
Witt P. L., Storer B. E., Bryan G. T., Brown R. R., Flashner M., Larocca A. T., Colby C. B., and Borden E. C. J Immunotherapy 13:191–200 (1993).
Chiang J., Gloff C., Yoshizawa C., and Williams G. Pharm Res 10:567–57 (1993).
Chiang J., Gloff C. A., Soike K., and Williams G. J Interferon Res 13:111–120 (1993).
WHO Expert Committee of Biological Standardization. 38th World Health Organization Technical Report, Series 771, p. 36–38 (1988).
Kenward M and Jones B. Design and Analysis of Cross-Over Trials. Chapman and Hall, 1989.
Canosi U., Macia M., Gazza L., Serlupi-Crescenzi O., Donini S., Antonetti F., and Galli G. J Immunol Methods 199:69–76 (1996).
Liberati A., Horisberger M., Palmisano L., Astolfi S., Nastari A., Mechati S., Villa A., Mancini S., Arzano S., Grignani F. J Interferon Res 12:329–336 (1992).
Liberati A. M., Garofani P., De Angelis V., Clemente F. D., Horisberger M., Cecchini M., Betti A. R., Palmisano L., Astolfi S., Nastari A., Villa A., Villa A., and Arzano S. J Interferon Res 14:61–69 (1994).
Paulesu L., Pessina G. P., and Bocci V. Proc Soc Exp Bio Med 200:414–417 (1992).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alam, J., Goelz, S., Rioux, P. et al. Comparative Pharmacokinetics and Pharmacodynamics of Two Recomhinant Human Interferon Beta-la (IFNβ-la) Products Administered Intramuscularly in Healthy Male and Female Volunteers. Pharm Res 14, 546–549 (1997). https://doi.org/10.1023/A:1012128406432
Issue Date:
DOI: https://doi.org/10.1023/A:1012128406432